Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
During the SARS-CoV-2 pandemic, a higher incidence of invasive pulmonary aspergillosis was observed in patients affected by Coronavirus disease 2019 (COVID-19), leading to the delineation of a new entity named COVID-19 associated pulmonary aspergillosis (CAPA). A predisposition to invasive infection...
Main Authors: | Alessandro Russo, Helen Linda Morrone, Salvatore Rotundo, Enrico Maria Trecarichi, Carlo Torti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/6/1364 |
Similar Items
-
Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients
by: Rafael Zaragoza, et al.
Published: (2023-01-01) -
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience
by: Alessandro Russo, et al.
Published: (2024-01-01) -
Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus
by: Benhur Joel Shadrach, et al.
Published: (2021-04-01) -
Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study
by: Felix Bergmann, et al.
Published: (2023-03-01) -
COVID-19 Associated Pulmonary Aspergillosis: A Case Series
by: Mira Yulianti, et al.
Published: (2022-04-01)